Morgan Stanley upgrades Gilead on HIV treatment growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| Gilead Sciences (NASDAQ: GILD) | Delayed: 147.10 +0.25 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.85 | 52 Week High | $108.63 | |||
| Open | $146.73 | 52 Week Low | $71.39 | |||
| Day High | $147.59 | P/E | 81.27 | |||
| Day Low | $144.65 | EPS | $1.81 | |||
| Volume | 4,489,683 | |||||
| Morgan Stanley (NYSE: MS) | Delayed: 187.44 -2.27 (1.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $189.71 | 52 Week High | $39.88 | |||
| Open | $186.81 | 52 Week Low | $21.16 | |||
| Day High | $188.54 | P/E | 131.08 | |||
| Day Low | $186.15 | EPS | $1.43 | |||
| Volume | 5,860,162 | |||||
